Targeting Ubiquitin-Specific Protease 7 (USP7): A Pharmacophore-Guided Drug Repurposing and Physics-Based Molecular Simulations Study
Kanan, T.; Kanan, D.; Erol, I.; Dogan, B.; Durdagi, S.
Show abstract
Ubiquitin-Specific Protease 7 (USP7) has emerged as a critical therapeutic target in cancer due to its regulatory roles of tumor suppressors, oncoproteins, and epigenetic modifiers. In this study, we present a comprehensive drug repurposing strategy to identify potential USP7 inhibitors from a curated library of 6,654 FDA-approved and investigational small molecules. Using structure-based pharmacophore models derived from USP7-inhibitor crystal structures, we conducted virtual screening to select candidates with favorable pharmacophoric alignment. The top 100 hits were subjected to short 10 ns molecular dynamics (MD) simulations and MM/GBSA binding energy calculations, narrowing down to 36 promising ligands. These were further evaluated through longer (100 ns) MD simulations, binding energy refinement, ligand clustering based on molecular fingerprints, and cancer-specific activity predictions using a binary QSAR model. Twelve compounds demonstrated favorable binding profiles, structural diversity, and high predicted anticancer activity, such as xantifibrate, etofylline clofibrate, and carafiban. This multi-tiered hybrid virtual screening pipeline highlights the potential of drug repurposing for the rapid identification of USP7 inhibitors, offering a cost-effective path toward novel anticancer therapeutics.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
Similar papers in this journal
- De novo drug designing coupled with brute force screening and structure guided lead optimization gives highly specific inhibitor of METTL3: a potential cure for Acute Myeloid Leukaemia 97%
- A strategy to optimize the peptide-based inhibitors against different mutants of the spike protein of SARS-CoV-2 96%
- Pharmacophore modeling, 2D-QSAR, Molecular Docking and ADME studies for the discovery of inhibitors of PBP2a in MRSA 95%
Similar papers in this journal
- Mechanistic insights into the Japanese Encephalitis Virus RNA dependent RNA polymerase protein inhibition by bioflavonoids from Azadirachta indica 97%
- Discovery of Z1362873773: A Novel Fascin Inhibitor from a Large Chemical Library for Colorectal Cancer 96%
- The Hidden Potential of PDE4 Inhibitor Rolipram: A Multifaceted Examination of its Inhibition of MMP2/9 Reveals Therapeutic Implications 96%
Similar papers in this journal
- Structural Models for a Series of Allosteric Inhibitors of IGF1R Kinase 96%
- Elucidation of Structural Mechanism of ATP Inhibition at the AAA1 Subunit of Cytoplasmic Dynein 1 Using a Chemical "Toolkit" 94%
- Single nucleotide polymorphism induces divergent dynamic patterns in CYP3A5: a microsecond scale biomolecular simulation of variants identified in Sub-Saharan African populations 94%
Similar papers in this journal
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.